University of Leicester
Browse

High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial

Download (999.38 kB)
journal contribution
posted on 2025-04-03, 09:27 authored by Joyee Basu, Dimitra Nikoletou, Chris Miles, Hamish MacLachlan, Gemma Parry-Williams, Fred Tilby-Jones, Paulo Bulleros, Zephryn Fanton, Claire Baker, Shane Purcell, Carmen Lech, Tracy Chapman, Peter Sage, Shams Wahid, Nabeel Sheikh, Shruti Jayakumar, Aneil Malhotra, Tracey Keteepe-Arachi, Belinda Gray, Gherardo Finocchiaro, Gerald Carr-White, Elijah Behr, Maite Tome, Jamie O’Driscoll, Irina Chis Ster, Sanjay Sharma, Michael Papadakis

Background and Aims The feasibility and impact of high intensity exercise programmes in patients with hypertrophic cardiomyopathy (HCM) are unknown. This study was conducted to determine the feasibility of a high intensity exercise programme and explore safety and efficacy outcomes in patients with HCM. Methods Participants were randomized to a 12-week supervised exercise programme (n = 40) in addition to usual care, or usual care alone (n = 40). All participants underwent assessment at baseline and 12 weeks. The exercise group was re-evaluated 6 months post-programme. Feasibility was assessed by (i) recruitment, adherence, and retention rates; (ii) staffing ratios; (iii) logistics; and (iv) acceptability of the intervention. The primary exploratory safety outcome was a composite of arrhythmia-related events. Exploratory secondary outcomes included changes in (i) cardiorespiratory fitness; (ii) cardiovascular risk factors; and (iii) quality of life, anxiety, and depression scores. Results Overall, 67 (84%) participants completed the study (n = 34 and n = 33 in the exercise and usual care groups, respectively). Reasons for non-adherence included travel, work, and family commitments. Resource provision complied with national cardiac rehabilitation standards. There was no difference between groups for the exploratory safety outcome (P = .99). At 12 weeks, the exercise group had a greater increase in peak oxygen consumption (VO2) [+4.1 mL/kg/min, 95% confidence interval (CI) 1.1, 7.1] and VO2 at anaerobic threshold (+2.3 mL/kg/min, 95% CI 0.4, 4.1), lower systolic blood pressure (−7.3 mmHg, 95% CI −11.7, −2.8) and body mass index (−0.8 kg/m2, 95% CI −1.1, −0.4), and greater improvement in hospital anxiety (−3, 95% CI −4.3, −1.7) and depression (−1.7, 95% CI −2.9, −0.5) scores, compared to the usual care group. Most exercise gains dissipated at 6 months. Conclusions A high intensity exercise programme is feasible in patients with HCM, with apparent cardiovascular and psychological benefits, and no increase in arrhythmias. A large-scale study is required to substantiate findings and assess long-term safety of high intensity exercise in HCM.

Funding

J.B. was funded by a research fellowship awarded by Cardiac Risk in the Young (registered charity number 1050845), Surrey, UK.

History

Author affiliation

College of Life Sciences Population Health Sciences

Version

  • VoR (Version of Record)

Published in

European Heart Journal

Publisher

Oxford University Press (OUP)

issn

0195-668X

eissn

1522-9645

Copyright date

2025

Available date

2025-04-03

Language

en

Deposited by

Dr Jamie O'Driscoll

Deposit date

2025-03-14

Data Access Statement

The data underlying this article cannot be shared publicly due to the privacy of individuals that participated in the study. The data will be shared on reasonable request to the corresponding author.

Usage metrics

    University of Leicester Publications

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC